⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21371251 | 1.00 | — | — | |
| SCHEMBL24153058 | 0.80 | — | — | |
| SCHEMBL16506663 | 0.78 | KISS1R (0.36) | — | |
| SCHEMBL258152 | 0.78 | SLC22A6 (0.50) | — | |
| SCHEMBL28603390 | 0.76 | ALDH1A1 (0.39) | — | |
| SCHEMBL7409827 | 0.76 | MMP2 (0.39) | — | |
| SCHEMBL5709309 | 0.76 | GABRP (0.48) | — | |
| SCHEMBL24770618 | 0.76 | SMN1; SMN2 (0.37) | — | |
| SCHEMBL10902055 | 0.75 | SLC22A6 (0.47) | — | |
| SCHEMBL11112412 | 0.75 | SLC22A6 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049536-A2 | POLYCYCLIC VIRAL INHIBITORS | GENELABS TECHNOLOGIES, INC. (US) | 2009-04-22 | — | — | EP | claimed |
| EP-2044083-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2009-04-08 | — | — | EP | claimed |
| WO-2008011521-A2 | POLYCYCLIC VIRAL INHIBITORS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-24 | — | — | WO | claimed |
| WO-2008008907-A2 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | claimed |
| WO-2008008912-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | claimed |
| EP-4273245-A1 | NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND SIRNA CONJUGATE CONTAINING THE NUCLEIC ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF | Suzhou Ribo Life Science Co., Ltd. (CN) | 2023-11-08 | — | — | EP | disclosed |
| WO-2023116764-A1 | NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, AND USE OF SAME, COMPOSITION AND CONJUGATE | 苏州瑞博生物技术股份有限公司 | 2023-06-29 | — | — | WO | disclosed |
| WO-2023088455-A1 | NUCLEIC ACID, PHARMACEUTICAL COMPOSITION CONTAINING SAME, SIRNA CONJUGATE, PREPARATION METHOD, AND USE | 苏州瑞博生物技术股份有限公司 | 2023-05-25 | — | — | WO | disclosed |
| WO-2023070076-A1 | COMPOUNDS FOR CANCERS DRIVEN BY BRAF MUTATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023284763-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE, COMPOSITION AND CONJUGATE CONTAINING DOUBLE-STRANDED OLIGONUCLEOTIDE, AND PREPARATION METHODS AND USES | 苏州瑞博生物技术股份有限公司 | 2023-01-19 | — | — | WO | disclosed |
| WO-2023284559-A1 | NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, AND PREPARATION METHOD AND USE | 苏州瑞博生物技术股份有限公司 | 2023-01-19 | — | — | WO | disclosed |
| EP-4023659-A1 | COMPOUND AND DRUG CONJUGATE, AND PREPARATION METHOD AND USE THEREOF | Suzhou Ribo Life Science Co., Ltd. (CN) | 2022-07-06 | — | — | EP | disclosed |
| WO-2020135581-A1 | NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州瑞博生物技术有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020135673-A1 | NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州瑞博生物技术有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020038377-A1 | NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, AND USE THEREOF | 苏州瑞博生物技术有限公司 | 2020-02-27 | — | — | WO | disclosed |
| EP-2049536-A2 | POLYCYCLIC VIRAL INHIBITORS | GENELABS TECHNOLOGIES, INC. (US) | 2009-04-22 | — | — | EP | disclosed |
| EP-2044083-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008011521-A2 | POLYCYCLIC VIRAL INHIBITORS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| WO-2008008907-A2 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008008912-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |